RE:RE:News and update Thats because it isn't good news. They are finally admitting that they are missing batch info and trial data. And at the rate they are doing source data verification, it should be next year instead of this summer that they can complete the phase 2. I strongly believe that they have known for some time that they can not complete the phase 2 without data that Aspire holds. Peter mentioned as much at the AGM. And how can you recreate trial data from site visits if you don't know who was treated with ACP or placebos? They pumped up the stock in December under the premise that they had recieved the trial data from Medrio when in fact they probably knew at the time that it was an incomplete data set. And ever since, they have strung along investors with increasingly longer timelines knowing full well that they can do nothing with their phase 2 trial unless they beat Aspire in court. So my conclusion is that they are basically pretending they can recreate the trial from site visits to show investors that A) they are working on it and B) they dont need to beat Aspire in court. I knew when they said 3 months for this process in April that it was a lie. Now they finally admit it will take longer but they aren't telling you that it is impossible without Aspires data and that they are simply stalling and hoping to win against Aspire next year sometime. This is just my best guess as to whats really going on but if you read between the lines, it makes sense. Smeenk is full of it and has been misleading investors for a long time. This is likely a lost cause and at the very least buckle up for another year of excuses and low priced desperate cash raises to pay lawyers. I hope im wrong but i haven't been thus far. My moneys basically gone so I'll just sit and watch this clown car show until it either miraculously works out or bursts into flame. Whichever comes first